top of page
  • Writer's pictureGillian Edwards

IPTN's third annual scientific conference connects people from around the world

On October 22, 2022, IPTN hosted its third international scientific conference virtually, using the forum to showcase type 1 diabetes (T1D) researchers, as well as professionals living with the disease. Topics included inter-individual glucose and insulin responses and the need for personalized therapeutic nutrition approaches, and insulin resistance as a feature across all types of T1D.

Speakers explored personal aspects of living with type 1 diabetes such as distress associated with eating, weight, and body image. A key theme was the importance for healthcare professionals to establish and foster a trusting and supportive relationship with clients that promotes self awareness, self acceptance, and responsibility for change.

If you missed the conference, recordings will be available in early 2023 through our Community of Practice, a diverse online gathering of people that's free and offers opportunity for further development, learning, and connection.

Missed the conference? Check out the full list of speakers and their topics:

  • Jelena Kolic, PhD. Inter-individual glucose and insulin responses: Making the case for personalized therapeutic nutrition.

  • Justin Gregory, MD. Hyperinsulinemia, insulin resistance, and adiposity in type 1 diabetes.

  • Kimber Simmons, MD. Nutrition and lifestyle clinical trials is type 1 diabetes: Past, present, and future. 

  • Gaja Andzel, MD. Clinical experience in therapeutic nutrition in T1D practice.

  • Suja Srikameswaran, PhD. A psychologists’ perspective to helping improve nutrition habits for people with type 1 diabetes.

  • Amy Rush, RD. Role of the RD in the management of T1D.

  • Beth McNally, RD, Caroline Roberts, MD, Andrew Koutnik, PhD. Report from IPTN’s clinical working group: Recommendations for therapeutic nutrition in T1D.

  • Andrew Koutnik, PhD, Linxi Mytkolli, Diabetes Action Canada, and Anne Marie MacDonald, MD. Patient/caregiver/advocacy panel

  • Jim Johnson, PhD. Beyond glucose control – hyperinsulinemia in chronic disease.

33 views0 comments


bottom of page